Skip to main navigation Skip to search Skip to main content

A phase 3, multicenter, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of Golcadomide plus R-CHOP chemotherapy vs placebo plus R-CHOP chemotherapy in participants with previously untreated high-risk large B-cell lymphoma (GOLSEEK-1)

Project: Clinical studies › Clinical Study (Industry project)

Project Details

Description

A phase 3, multicenter, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of Golcadomide plus R-CHOP chemotherapy vs placebo plus R-CHOP chemotherapy in participants with previously untreated high-risk large B-cell lymphoma (GOLSEEK-1)
StatusActive
Effective start/end date25.06.2024 → 31.12.2027

Fields of science

  • 302024 Haematology
  • 302055 Oncology